During the past decade, MCBK conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MCBK" #1 sponsor was "Pfizer" with 5 trials, followed by "4SC AG" with 1 trials sponsored, "Abbott Nutrition" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MCBK" #1 collaborator was "Janssen Biotech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "MCBK" are "Rheumatoid Arthritis" (3 trials), "Atopic Dermatitis" (2 trials), "Dermatitis, Atopic" (2 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Dermatitis" (1 trials). Many other conditions were trialed in "MCBK" in a lesser frequency.

Most popular intervention types in "MCBK" are "Drug" (9 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Abrocitinib 200 mg" (2 trials), "Abrocitinib 100 mg" (1 trials), "Aprocitentan 12.5 mg" (1 trials) and "Aprocitentan 25 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "MCBK" are 10 trials for "All" genders.

Currently, there are NaN active trials in "MCBK". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in MCBK, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MCBK, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".